The DOI matches its Crossref record; 1,227 of the 1,227 references it cites were found in a registry or an index.
Dopamine, Immunity, and Disease
Open accessAbstract
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function, regulating many processes including reward, movement, and cognition. Dopamine also regulates critical functions in peripheral organs, such as blood pressure, renal activity, and intestinal motility. Beyond these functions, a growing body of evidence indicates that dopamine is an important immunoregulatory factor. Most types of immune cells express dopamine receptors and other dopaminergic proteins, and many immune cells take up, produce, store, and/or release dopamine, suggesting that dopaminergic immunomodulation is important for immune function. Targeting these pathways could be a promising avenue for the treatment of inflammation and disease, but despite increasing research in this area, data on the specific effects of dopamine on many immune cells and disease processes remain inconsistent and poorly understood. Therefore, this review integrates the current knowledge of the role of dopamine in immune cell function and inflammatory signaling across systems. We also discuss the current understanding of dopaminergic regulation of immune signaling in the CNS and peripheral tissues, highlighting the role of dopaminergic immunomodulation in diseases such as Parkinson's disease, several neuropsychiatric conditions, neurologic human immunodeficiency virus, inflammatory bowel disease, rheumatoid arthritis, and others. Careful consideration is given to the influence of experimental design on results, and we note a number of areas in need of further research. Overall, this review integrates our knowledge of dopaminergic immunology at the cellular, tissue, and disease level and prompts the development of therapeutics and strategies targeted toward ameliorating disease through dopaminergic regulation of immunity. SIGNIFICANCE STATEMENT: Canonically, dopamine is recognized as a neurotransmitter involved in the regulation of movement, cognition, and reward. However, dopamine also acts as an immune modulator in the central nervous system and periphery. This review comprehensively assesses the current knowledge of dopaminergic immunomodulation and the role of dopamine in disease pathogenesis at the cellular and tissue level. This will provide broad access to this information across fields, identify areas in need of further investigation, and drive the development of dopaminergic therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 1,227
Phagocyte-derived catecholamines enhance acute inflammatory injury
Flierl, M. A., Rittirsch, D., Nadeau, B. A., Chen, A. J., Sarma, J. V., Zetoune, F. S., McGuire, S. R., List, R. P., Day, D. E., Hoesel, L. M., et al. (2007) · Nature · doi:10.1038/nature06185 · Cited by 475
Cytotoxic and genotoxic potential of dopamine
Stokes, A. H., Hastings, T. G., & Vrana, K. E. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6<659::aid-jnr1>3.0.co;2-c · Cited by 469
The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress
Juárez Olguín, H., Calderón Guzmán, D., Hernández García, E., & Barragán Mejía, G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9730467 · Cited by 462
Slominski (2012) · doi:10.1007/978-3-642-19683-6_1 · Cited by 461
Anxiety disorders and inflammation in a large adult cohort
Vogelzangs, N., Beekman, A. T. F., de Jonge, P., & Penninx, B. W. J. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.27 · Cited by 458
Hernández-López, S., Tkatch, T., Perez-Garci, E., Galarraga, E., Bargas, J., Hamm, H., & Surmeier, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-08987.2000 · Cited by 443
Alcocer-Gómez, E., de Miguel, M., Casas-Barquero, N., Núñez-Vasco, J., Sánchez-Alcazar, J. A., Fernández-Rodríguez, A., & Cordero, M. D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.10.017 · Cited by 443
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6
Zalcman, S., Green-Johnson, J. M., Murray, L., Nance, D. M., Dyck, D., Anisman, H., & Greenberg, A. H. (1994) · Brain Research · doi:10.1016/0006-8993(94)90006-x · Cited by 439
Immune surveillance in the central nervous system
Ousman, S. S., & Kubes, P. (2012) · Nature Neuroscience · doi:10.1038/nn.3161 · Cited by 436
Cattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K. J., Craig, I. W., Anacker, C., Zunsztain, P. A., McGuffin, P., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.191 · Cited by 436
Ghersi-Egea, J.-F., Strazielle, N., Catala, M., Silva-Vargas, V., Doetsch, F., & Engelhardt, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1807-1 · Cited by 436
Wang, H., Xu, J., Lazarovici, P., Quirion, R., & Zheng, W. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00255 · Cited by 436
Local cues establish and maintain region-specific phenotypes of basal ganglia microglia
De Biase, L. M., Schuebel, K. E., Fusfeld, Z. H., Jair, K., Hawes, I. A., Cimbro, R., Zhang, H.-Y., Liu, Q.-R., Shen, H., Xi, Z.-X., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.020 · Cited by 432
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431
Lee, E., Hwang, I., Park, S., Hong, S., Hwang, B., Cho, Y., Son, J., & Yu, J.-W. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0124-5 · Cited by 431
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 427
Dahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423
Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission
Kebabian, J. W., & Greengard, P. (1971) · Science · doi:10.1126/science.174.4016.1346 · Cited by 421
Mechanisms of dopamine transporter regulation in normal and disease states
Vaughan, R. A., & Foster, J. D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.005 · Cited by 419
The Akt–GSK-3 signaling cascade in the actions of dopamine
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.006 · Cited by 419
Cignarella, F., Filipello, F., Bollman, B., Cantoni, C., Locca, A., Mikesell, R., Manis, M., Ibrahim, A., Deng, L., Benitez, B. A., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02193-z · Cited by 418
Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin
Shao, W., Zhang, S.-Z., Tang, M., Zhang, X.-H., Zhou, Z., Yin, Y.-Q., Zhou, Q.-B., Huang, Y.-Y., Liu, Y.-J., Wawrousek, E., et al. (2013) · Nature · doi:10.1038/nature11748 · Cited by 418
Uher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010094 · Cited by 418
Cyclic AMP: Master Regulator of Innate Immune Cell Function
Serezani, C. H., Ballinger, M. N., Aronoff, D. M., & Peters-Golden, M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0091tr · Cited by 415
Croisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K., & Graeber, M. B. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-14 · Cited by 414
von Känel, R., Hepp, U., Kraemer, B., Traber, R., Keel, M., Mica, L., & Schnyder, U. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.06.009 · Cited by 408
Understanding nutrition, depression and mental illnesses
Sathyanarayana Rao, T., Asha, M., Ramesh, B., & Jagannatha Rao, K. (2008) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.42391 · Cited by 408
Knable, M. B., Barci, B. M., Webster, M. J., Meador-Woodruff, J., & Torrey, E. F. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001471 · Cited by 407
Lyte, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003726 · Cited by 399
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
Tisdale, J. E., Chung, M. K., Campbell, K. B., Hammadah, M., Joglar, J. A., Leclerc, J., Rajagopalan, B., & On behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing (2020) · Circulation · doi:10.1161/cir.0000000000000905 · Cited by 399
Slifstein, M., van de Giessen, E., Van Snellenberg, J., Thompson, J. L., Narendran, R., Gil, R., Hackett, E., Girgis, R., Ojeil, N., Moore, H., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2414 · Cited by 398
Brooks, D. J., Ibanez, V., Sawle, G. V., Playford, E. D., Quinn, N., Mathias, C. J., Lees, A. J., Marsden, C. D., Bannister, R., & Frackowiak, R. S. J. (1992) · Annals of Neurology · doi:10.1002/ana.410310209 · Cited by 396
Substantial Production of Dopamine in the Human Gastrointestinal Tract
Eisenhofer, G., Åneman, A., Friberg, P., Hooper, D., Fåndriks, L., Lonroth, H., Hunyady, B., & Mezey, E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4339 · Cited by 394
Eugenin, E. A., Osiecki, K., Lopez, L., Goldstein, H., Calderon, T. M., & Berman, J. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3863-05.2006 · Cited by 392
Patente, T. A., Pinho, M. P., Oliveira, A. A., Evangelista, G. C. M., Bergami-Santos, P. C., & Barbuto, J. A. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03176 · Cited by 392
Felger, J. C., & Miller, A. H. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.003 · Cited by 391
Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis*
De Backer, D., Aldecoa, C., Njimi, H., & Vincent, J.-L. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31823778ee · Cited by 389
Microglia and astrocyte dysfunction in parkinson's disease
Kam, T.-I., Hinkle, J. T., Dawson, T. M., & Dawson, V. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105028 · Cited by 389
Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia
Aubert, I., Guigoni, C., Håkansson, K., Li, Q., Dovero, S., Barthe, N., Bioulac, B. H., Gross, C. E., Fisone, G., Bloch, B., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20296 · Cited by 387
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
Lindestam Arlehamn, C. S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15626-w · Cited by 386
Arnsten, A. F. T., & Pliszka, S. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.020 · Cited by 383
Wada, N. I., Jacobson, L. P., Margolick, J. B., Breen, E. C., Macatangay, B., Penugonda, S., Martínez-Maza, O., & Bream, J. H. (2015) · AIDS · doi:10.1097/qad.0000000000000545 · Cited by 383
Prolactin and dopamine: What is the connection? A Review Article
Fitzgerald, P., & Dinan, T. G. (2008) · Journal of Psychopharmacology · doi:10.1177/0269216307087148 · Cited by 383
Striatal dopamine neurotransmission: Regulation of release and uptake
Sulzer, D., Cragg, S. J., & Rice, M. E. (2016) · Basal Ganglia · doi:10.1016/j.baga.2016.02.001 · Cited by 382
Capuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2094 · Cited by 382
Brydon, L., Harrison, N. A., Walker, C., Steptoe, A., & Critchley, H. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.007 · Cited by 381
Adrenal insufficiency during septic shock*
Marik, P. E., & Zaloga, G. P. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301000-00022 · Cited by 379
Neutrophils at the crossroads of innate and adaptive immunity
Rosales, C. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mir0220-574rr · Cited by 372
NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings
Kaufmann, F. N., Costa, A. P., Ghisleni, G., Diaz, A. P., Rodrigues, A. L. S., Peluffo, H., & Kaster, M. P. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.03.002 · Cited by 370
Bergquist, J., Tarkowski, A., Ekman, R., & Ewing, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12912 · Cited by 370
Microglial Cells: The Main HIV-1 Reservoir in the Brain
Wallet, C., De Rovere, M., Van Assche, J., Daouad, F., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Van Lint, C., Rohr, O., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00362 · Cited by 368
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review
Trépanier, M. O., Hopperton, K. E., Mizrahi, R., Mechawar, N., & Bazinet, R. P. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.90 · Cited by 360
Conservation and divergence in the transcriptional programs of the human and mouse immune systems
Shay, T., Jojic, V., Zuk, O., Rothamel, K., Puyraimond-Zemmour, D., Feng, T., Wakamatsu, E., Benoist, C., Koller, D., Regev, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222738110 · Cited by 359
Maes, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00088-8 · Cited by 357
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET
Sandiego, C. M., Gallezot, J.-D., Pittman, B., Nabulsi, N., Lim, K., Lin, S.-F., Matuskey, D., Lee, J.-Y., O’Connor, K. C., Huang, Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511003112 · Cited by 356
A Prescription for Human Immunology
Davis, M. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.12.003 · Cited by 345
Rice, M. E., & Cragg, S. J. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.02.004 · Cited by 344
Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder
Hoge, E. A., Brandstetter, K., Moshier, S., Pollack, M. H., Wong, K. K., & Simon, N. M. (2009) · Depression and Anxiety · doi:10.1002/da.20564 · Cited by 343
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
For the German Association of Neuro-AIDS und Neuro-Infectiology (DGNANI), Eggers, C., Arendt, G., Hahn, K., Husstedt, I. W., Maschke, M., Neuen-Jacob, E., Obermann, M., Rosenkranz, T., Schielke, E., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8503-2 · Cited by 339
Current status and prospects of HIV treatment
Cihlar, T., & Fordyce, M. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.004 · Cited by 337
Effects of cytokines and infections on brain neurochemistry
Dunn, A. J. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.04.002 · Cited by 336
Myeloid Cells in the Central Nervous System
Herz, J., Filiano, A. J., Wiltbank, A. T., Yogev, N., & Kipnis, J. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.007 · Cited by 332
Misuse of Stimulant Medication Among College Students: A Comprehensive Review and Meta-analysis
Benson, K., Flory, K., Humphreys, K. L., & Lee, S. S. (2015) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-014-0177-z · Cited by 328
Mirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327
Fischer, K., Ruiz, H. H., Jhun, K., Finan, B., Oberlin, D. J., van der Heide, V., Kalinovich, A. V., Petrovic, N., Wolf, Y., Clemmensen, C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4316 · Cited by 325
The immunoregulatory role of dopamine: An update
Sarkar, C., Basu, B., Chakroborty, D., Dasgupta, P. S., & Basu, S. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.10.015 · Cited by 323
Gleeson, L. E., Sheedy, F. J., Palsson-McDermott, E. M., Triglia, D., O’Leary, S. M., O’Sullivan, M. P., O’Neill, L. A. J., & Keane, J. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501612 · Cited by 319
Xia, Z., Depierre, J. W., & Nässberger, L. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00111-7 · Cited by 318
Reduced basal ganglia volume in HIV‐1‐associated dementia: Results from quantitative neuroimaging
Aylward, E. H., Henderer, J. D., McArthur, J. C., Brettschneider, P. D., Harris, G. J., Barta, P. E., & Pearlson, G. D. (1993) · Neurology · doi:10.1212/wnl.43.10.2099 · Cited by 317
Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense
Garaude, J., Acín-Pérez, R., Martínez-Cano, S., Enamorado, M., Ugolini, M., Nistal-Villán, E., Hervás-Stubbs, S., Pelegrín, P., Sander, L. E., Enríquez, J. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3509 · Cited by 313
Metabolic regulation of NLRP 3
Hughes, M. M., & O'Neill, L. A. J. (2018) · Immunological Reviews · doi:10.1111/imr.12608 · Cited by 311
Urinary Catecholamine Excretion and Severity of PTSD Symptoms in Vietnam Combat Veterans
YEHUDA, R., SOUTHWICK, S., GILLER, E. L., XIAOWAN, &., & MASON, J. W. (1992) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199205000-00006 · Cited by 310
Plichta, D. R., Graham, D. B., Subramanian, S., & Xavier, R. J. (2019) · Cell · doi:10.1016/j.cell.2019.07.045 · Cited by 310
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306
Daniele, S. G., Béraud, D., Davenport, C., Cheng, K., Yin, H., & Maguire-Zeiss, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.2005965 · Cited by 303
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo
Richmond, J. M., Strassner, J. P., Zapata, L., Garg, M., Riding, R. L., Refat, M. A., Fan, X., Azzolino, V., Tovar-Garza, A., Tsurushita, N., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7710 · Cited by 301
Macrophages: Their Emerging Roles in Bone
Sinder, B. P., Pettit, A. R., & McCauley, L. K. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2735 · Cited by 300
Bronson, S. L., & Bale, T. L. (2014) · Endocrinology · doi:10.1210/en.2014-1040 · Cited by 299
Neuroinflammation as a risk factor for attention deficit hyperactivity disorder
Dunn, G. A., Nigg, J. T., & Sullivan, E. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.005 · Cited by 299
Papakostas, G. I., Mischoulon, D., Shyu, I., Alpert, J. E., & Fava, M. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09081198 · Cited by 297
Pathway-Specific Dopamine Abnormalities in Schizophrenia
Weinstein, J. J., Chohan, M. O., Slifstein, M., Kegeles, L. S., Moore, H., & Abi-Dargham, A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.03.2104 · Cited by 297
Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control
Próchnicki, T., & Latz, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.018 · Cited by 297
de la Mora, M. P., Gallegos-Cari, A., Arizmendi-García, Y., Marcellino, D., & Fuxe, K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.010 · Cited by 296
O'Connor, J. C., Lawson, M. A., André, C., Briley, E. M., Szegedi, S. S., Lestage, J., Castanon, N., Herkenham, M., Dantzer, R., & Kelley, K. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802722 · Cited by 295
Differentiation of Mesencephalic Progenitor Cells into Dopaminergic Neurons by Cytokines
Ling, Z. D., Potter, E. D., Lipton, J. W., & Carvey, P. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6715 · Cited by 295
Vasopressors for the treatment of septic shock: Systematic review and meta-analysis.
Avni, T., Lador, A., Lev, S., Leibovici, L., Paul, M., & Grossman, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129305 · Cited by 293
Tonini, M., Cipollina, L., Poluzzi, E., Crema, F., Corazza, G. R., & De Ponti, F. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01867.x · Cited by 291
The role of dopamine in the mechanism of action of antidepressant drugs
D'Aquila, P. S., Collu, M., Gessa, G. L., & Serra, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00566-5 · Cited by 289
Understanding wiring and volume transmission
Agnati, L. F., Guidolin, D., Guescini, M., Genedani, S., & Fuxe, K. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.03.003 · Cited by 287
Matt, S. M., & Gaskill, P. J. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09851-4 · Cited by 287
Self-citationCortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
Mondelli, V., Ciufolini, S., Belvederi Murri, M., Bonaccorso, S., Di Forti, M., Giordano, A., Marques, T. R., Zunszain, P. A., Morgan, C., Murray, R. M., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv028 · Cited by 286
Stouffer, M. A., Woods, C. A., Patel, J. C., Lee, C. R., Witkovsky, P., Bao, L., Machold, R. P., Jones, K. T., de Vaca, S. C., Reith, M. E. A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9543 · Cited by 286
Maternal Immune Activation and Neuropsychiatric Illness: A Translational Research Perspective
Brown, A. S., & Meyer, U. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17121311 · Cited by 285
Intraneuronal dopamine-quinone synthesis: a review
Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284
Anxiety in relation to inflammation and coagulation markers, among healthy adults: The ATTICA Study
Pitsavos, C., Panagiotakos, D. B., Papageorgiou, C., Tsetsekou, E., Soldatos, C., & Stefanadis, C. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.001 · Cited by 283
Venton, B. J., Zhang, H., Garris, P. A., Phillips, P. E. M., Sulzer, D., & Wightman, R. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02109.x · Cited by 283
Dopamine release in the basal ganglia
Rice, M. E., Patel, J. C., & Cragg, S. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.066 · Cited by 282
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy
Honeycutt, J. B., Thayer, W. O., Baker, C. E., Ribeiro, R. M., Lada, S. M., Cao, Y., Cleary, R. A., Hudgens, M. G., Richman, D. D., & Garcia, J. V. (2017) · Nature Medicine · doi:10.1038/nm.4319 · Cited by 281
G Protein–Coupled Receptor Signaling Through β-Arrestin–Dependent Mechanisms
Jean-Charles, P.-Y., Kaur, S., & Shenoy, S. K. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000482 · Cited by 280
Chaudhry, I. B., Hallak, J., Husain, N., Minhas, F., Stirling, J., Richardson, P., Dursun, S., Dunn, G., & Deakin, B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444941 · Cited by 279
Hoffman, B. J., Hansson, S. R., Mezey, É., & Palkovits, M. (1998) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0168 · Cited by 279
Prominence of the dopamine D2 short isoform in dopaminergic pathways
Khan, Z. U., Mrzljak, L., Gutierrez, A., de la Calle, A., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7731 · Cited by 278
Cosentino, M., Fietta, A. M., Ferrari, M., Rasini, E., Bombelli, R., Carcano, E., Saporiti, F., Meloni, F., Marino, F., & Lecchini, S. (2007) · Blood · doi:10.1182/blood-2006-01-028423 · Cited by 278
The role of dopamine in epilepsy
Starr, M. S. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199602)22:2<159::aid-syn8>3.0.co;2-c · Cited by 278
Westin, J. E., Vercammen, L., Strome, E. M., Konradi, C., & Cenci, M. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.032 · Cited by 277
Li, Z. S., Schmauss, C., Cuenca, A., Ratcliffe, E., & Gershon, M. D. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4720-05.2006 · Cited by 276
Receptors induce chemotaxis by releasing the βγ subunit of G i , not by activating G q or G s
Neptune, E. R., & Bourne, H. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14489 · Cited by 274
Neuroinflammation in Bipolar Depression
Benedetti, F., Aggio, V., Pratesi, M. L., Greco, G., & Furlan, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00071 · Cited by 274
Dzamko, N., Gysbers, A., Perera, G., Bahar, A., Shankar, A., Gao, J., Fu, Y., & Halliday, G. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1648-8 · Cited by 273
PTSD is associated with an excess of inflammatory immune activities
Gill, J. M., Saligan, L., Woods, S., & Page, G. (2009) · Perspectives in Psychiatric Care · doi:10.1111/j.1744-6163.2009.00229.x · Cited by 271
Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse
Lacagnina, M. J., Rivera, P. D., & Bilbo, S. D. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.121 · Cited by 271
Darmopil, S., Martín, A. B., De Diego, I. R., Ares, S., & Moratalla, R. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.025 · Cited by 271
Kim, Y.-K., & Shin, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170915141036 · Cited by 271
Sereti, I., Krebs, S. J., Phanuphak, N., Fletcher, J. L., Slike, B., Pinyakorn, S., O'Connell, R. J., Rupert, A., Chomont, N., Valcour, V., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw683 · Cited by 269
Esposito, G., Capoccia, E., Turco, F., Palumbo, I., Lu, J., Steardo, A., Cuomo, R., Sarnelli, G., & Steardo, L. (2014) · Gut · doi:10.1136/gutjnl-2013-305005 · Cited by 268
Influence of HAART on HIV-Related CNS Disease and Neuroinflammation
Anthony, I. C., Ramage, S. N., Carnie, F. W., Simmonds, P., & Bell, J. E. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.529 · Cited by 267
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Li, P., L. Snyder, G., & E. Vanover, K. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160608084834 · Cited by 266
Brain changes in a maternal immune activation model of neurodevelopmental brain disorders
Bergdolt, L., & Dunaevsky, A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.002 · Cited by 265
Rogers, J., Mastroeni, D., Leonard, B., Joyce, J., & Grover, A. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82012-5 · Cited by 260
Zweifel, L. S., Fadok, J. P., Argilli, E., Garelick, M. G., Jones, G. L., Dickerson, T. M. K., Allen, J. M., Mizumori, S. J. Y., Bonci, A., & Palmiter, R. D. (2011) · Nature Neuroscience · doi:10.1038/nn.2808 · Cited by 260
McKenna, F., McLaughlin, P. J., Lewis, B. J., Sibbring, G. C., Cummerson, J. A., Bowen-Jones, D., & Moots, R. J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00280-1 · Cited by 259
Kawagoe, K. T., Garris, P. A., Wiedemann, D. J., & Wightman, R. M. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90470-m · Cited by 258
Kopec, A. M., Smith, C. J., Ayre, N. R., Sweat, S. C., & Bilbo, S. D. (2018) · Nature Communications · doi:10.1038/s41467-018-06118-z · Cited by 258
Role of Inflammation in Suicide: From Mechanisms to Treatment
Brundin, L., Bryleva, E. Y., & Thirtamara Rajamani, K. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.116 · Cited by 257
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
DeFronzo, R. A. (2011) · Diabetes Care · doi:10.2337/dc11-0064 · Cited by 257
Rubí, B., Ljubicic, S., Pournourmohammadi, S., Carobbio, S., Armanet, M., Bartley, C., & Maechler, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505560200 · Cited by 256
Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure
Hampton, Jr., van Veldhuisen, D., Kleber, F., Cowley, A., Ardia, A., Block, P., Cortina, A., Cserhalmi, L., Follath, F., Jensen, G., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10488-8 · Cited by 256
Immune variations in bipolar disorder: phasic differences
Ortiz‐Domínguez, A., Hernández, M. E., Berlanga, C., Gutiérrez‐Mora, D., Moreno, J., Heinze, G., & Pavón, L. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00493.x · Cited by 255
Molecular Signaling Mechanisms Underlying Epileptogenesis
McNamara, J. O., Huang, Y. Z., & Leonard, A. S. (2006) · Science's STKE · doi:10.1126/stke.3562006re12 · Cited by 253
Distribution of Brain HIV Load in AIDS
Wiley, C. A., Soontornniyomkij, V., Radhakrishnan, L., Masliah, E., Mellors, J., Hermann, S. A., Dailey, P., & Achim, C. L. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00153.x · Cited by 253
Eugenin, E. A., Clements, J. E., Zink, M. C., & Berman, J. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1460-11.2011 · Cited by 251
Crowe, S., Zhu, T., & Muller, W. A. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0503204 · Cited by 251
Thawkar, B. S., & Kaur, G. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.11.010 · Cited by 249
Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson's Disease
Haque, M. E., Akther, M., Jakaria, M., Kim, I., Azam, S., & Choi, D. (2020) · Movement Disorders · doi:10.1002/mds.27874 · Cited by 247
Astrocyte-like glia in the peripheral nervous system: an immunohistochemical study of enteric glia
Jessen, K., & Mirsky, R. (1983) · The Journal of Neuroscience · doi:10.1523/jneurosci.03-11-02206.1983 · Cited by 246
MAPK Signal Transduction Underlying Brain Inflammation and Gliosis as Therapeutic Target
Kaminska, B., Gozdz, A., Zawadzka, M., Ellert‐Miklaszewska, A., & Lipko, M. (2009) · The Anatomical Record · doi:10.1002/ar.21047 · Cited by 246
Nitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease
Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo‐Dukelow, M., Chaudhuri, A., Ciborowski, P., Cerny, R., Gelman, B., Thomas, M. P., Mosley, R. L., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05087.x · Cited by 244
Intrarenal Dopamine: A Key Signal in the Interactive Regulation of Sodium Metabolism
Aperia, A. C. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.621 · Cited by 244
JOSEFSSON, E., BERGQUIST, J., EKMAN, R., & TARKOWSKI, A. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-653.x · Cited by 243
Ferri, G.-L., Probert, L., Cocchia, D., Michetti, F., Marangos, P. J., & Polak, J. M. (1982) · Nature · doi:10.1038/297409a0 · Cited by 243
Winter, C., Djodari-Irani, A., Sohr, R., Morgenstern, R., Feldon, J., Juckel, G., & Meyer, U. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009206 · Cited by 242
p53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain
Mogi, M., Kondo, T., Mizuno, Y., & Nagatsu, T. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.003 · Cited by 242
Skalhegg, B. S. (1997) · Frontiers in Bioscience · doi:10.2741/a195 · Cited by 242
Dopamine Receptors and Neurodegeneration
Claudia, R., Israel, C., & Benjamín, F. (2015) · Aging and disease · doi:10.14336/ad.2015.0330 · Cited by 241
Dopamine and noradrenaline control distinct functions in rodent microglial cells
Färber, K., Pannasch, U., & Kettenmann, H. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.01.003 · Cited by 238
Fever, febrile seizures and epilepsy
Dubé, C. M., Brewster, A. L., Richichi, C., Zha, Q., & Baram, T. Z. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.07.006 · Cited by 238
Hu, G., Guo, M., Xu, J., Wu, F., Fan, J., Huang, Q., Yang, G., Lv, Z., Wang, X., & Jin, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01998 · Cited by 237
The metabolic pathology of the AIDS dementia complex
Rottenberg, D. A., Moeller, J. R., Strother, S. C., Sidtis, J. J., Navia, B. A., Dhawan, V., Ginos, J. Z., & Price, R. W. (1987) · Annals of Neurology · doi:10.1002/ana.410220605 · Cited by 236
(2006) · PubMed · Cited by 234
The Dopamine Theory of Attention Deficit Hyperactivity Disorder (ADHD)
Levy, F. (1991) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679109077746 · Cited by 234
Identification of Dopamine D1–D3 Receptor Heteromers
Marcellino, D., Ferré, S., Casadó, V., Cortés, A., Le Foll, B., Mazzola, C., Drago, F., Saur, O., Stark, H., Soriano, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710349200 · Cited by 232
Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review
Instanes, J. T., Klungsøyr, K., Halmøy, A., Fasmer, O. B., & Haavik, J. (2018) · Journal of Attention Disorders · doi:10.1177/1087054716669589 · Cited by 232
Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes
Stahl, S. M. (2017) · CNS Spectrums · doi:10.1017/s1092852917000608 · Cited by 232
Autoimmune seizures and epilepsy
Geis, C., Planagumà, J., Carreño, M., Graus, F., & Dalmau, J. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125178 · Cited by 232
Asano, K., Takahashi, N., Ushiki, M., Monya, M., Aihara, F., Kuboki, E., Moriyama, S., Iida, M., Kitamura, H., Qiu, C.-H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8802 · Cited by 231
Brami-Cherrier, K., Valjent, E., Garcia, M., Pagès, C., Hipskind, R. A., & Caboche, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08911.2002 · Cited by 230
Hamby, M. E., Coppola, G., Ao, Y., Geschwind, D. H., Khakh, B. S., & Sofroniew, M. V. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1256-12.2012 · Cited by 228
Biologics for targeting inflammatory cytokines, clinical uses, and limitations
Rider, P., Carmi, Y., & Cohen, I. (2016) · International Journal of Cell Biology · doi:10.1155/2016/9259646 · Cited by 226
The inflammation hypothesis in geriatric depression
Alexopoulos, G. S., & Morimoto, S. S. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2672 · Cited by 226
Glucuronides in the gut: Sugar-driven symbioses between microbe and host
Pellock, S. J., & Redinbo, M. R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.767434 · Cited by 225
Yan, Z., Feng, J., Fienberg, A. A., & Greengard, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11607 · Cited by 224
Mimiaga, M. J., Reisner, S. L., Grasso, C., Crane, H. M., Safren, S. A., Kitahata, M. M., Schumacher, J. E., Mathews, W. C., & Mayer, K. H. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301162 · Cited by 224
The dopamine D3 receptor, a quarter century later
Sokoloff, P., & Le Foll, B. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13390 · Cited by 224
McClain, J. L., Grubišić, V., Fried, D., Gomez-Suarez, R. A., Leinninger, G. M., Sévigny, J., Parpura, V., & Gulbransen, B. D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.061 · Cited by 223
Mattei, D., Ivanov, A., Ferrai, C., Jordan, P., Guneykaya, D., Buonfiglioli, A., Schaafsma, W., Przanowski, P., Deuther-Conrad, W., Brust, P., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.80 · Cited by 222
Besser, M. J., Ganor, Y., & Levite, M. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.013 · Cited by 222
Loeb, H. S., Bredakis, J., & Gunner, R. M. (1977) · Circulation · doi:10.1161/01.cir.55.2.375 · Cited by 222
Anand, D., Colpo, G. D., Zeni, G., Zeni, C. P., & Teixeira, A. L. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00228 · Cited by 221
The HIV Reservoir in Monocytes and Macrophages
Wong, M. E., Jaworowski, A., & Hearps, A. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01435 · Cited by 221
Protective Functions of Reactive Astrocytes Following Central Nervous System Insult
Linnerbauer, M., & Rothhammer, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573256 · Cited by 220
Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation
Junker, F., Gordon, J., & Qureshi, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01393 · Cited by 219
Hiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012) · Psychological Medicine · doi:10.1017/s0033291712000128 · Cited by 219
Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States
Hartzler, B., Dombrowski, J. C., Crane, H. M., Eron, J. J., Geng, E. H., Christopher Mathews, W., Mayer, K. H., Moore, R. D., Mugavero, M. J., Napravnik, S., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-016-1584-6 · Cited by 219
Vuillermot, S., Weber, L., Feldon, J., & Meyer, U. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5408-09.2010 · Cited by 217
Renal Dopamine Receptors in Health and Hypertension
Jose, P. A., Eisner, G. M., & Felder, R. A. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00027-8 · Cited by 216
Alcocer-Gómez, E., Casas-Barquero, N., Williams, M. R., Romero-Guillena, S. L., Cañadas-Lozano, D., Bullón, P., Sánchez-Alcazar, J. A., Navarro-Pando, J. M., & Cordero, M. D. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.028 · Cited by 215
Felger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.115 · Cited by 214
Felger, J. C., Alagbe, O., Hu, F., Mook, D., Freeman, A. A., Sanchez, M. M., Kalin, N. H., Ratti, E., Nemeroff, C. B., & Miller, A. H. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.026 · Cited by 214
Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
Xie, H., Zhou, F., Liu, L., Zhu, G., Li, Q., Li, C., & Gao, T. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.09.003 · Cited by 214
The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell
Passante, E., & Frankish, N. (2009) · Inflammation Research · doi:10.1007/s00011-009-0074-y · Cited by 214
Villarán, R. F., Espinosa‐Oliva, A. M., Sarmiento, M., De Pablos, R. M., Argüelles, S., Delgado‐Cortés, M. J., Sobrino, V., Van Rooijen, N., Venero, J. L., Herrera, A. J., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06879.x · Cited by 214
Turrin, N. P., & Rivest, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.010 · Cited by 212
Pathogenesis of HIV in the Central Nervous System
Valcour, V., Sithinamsuwan, P., Letendre, S., & Ances, B. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0070-4 · Cited by 211
Syed, S. A., Beurel, E., Loewenstein, D. A., Lowell, J. A., Craighead, W. E., Dunlop, B. W., Mayberg, H. S., Dhabhar, F., Dietrich, W. D., Keane, R. W., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.001 · Cited by 211
Reciprocal Regulation of Dopamine D1 and D3 Receptor Function and Trafficking by Heterodimerization
Fiorentini, C., Busi, C., Gorruso, E., Gotti, C., Spano, P., & Missale, C. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043885 · Cited by 210
Monocyte/macrophages and their role in HIV neuropathogenesis
Burdo, T. H., Lackner, A., & Williams, K. C. (2013) · Immunological Reviews · doi:10.1111/imr.12068 · Cited by 208
Antonini, A., Schwarz, J., Oertel, W. H., Pogarell, O., & Leenders, K. L. (1997) · Movement Disorders · doi:10.1002/mds.870120107 · Cited by 208
Hemmings, H., Nairn, A., Aswad, D., & Greengard, P. (1984) · The Journal of Neuroscience · doi:10.1523/jneurosci.04-01-00099.1984 · Cited by 207
Rubí, B., & Maechler, P. (2010) · Endocrinology · doi:10.1210/en.2010-0745 · Cited by 207
Enteric glia: the most alimentary of all glia
Grubišić, V., & Gulbransen, B. D. (2017) · The Journal of Physiology · doi:10.1113/jp271021 · Cited by 207
Making Mouse Models That Reflect Human Immune Responses
Tao, L., & Reese, T. A. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.12.007 · Cited by 207
Magro, F., Vieira-Coelho, M. A., Fraga, S., Serräo, M. P., Veloso, F. T., Ribeiro, T., & Soares-da-Silva, P. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1013256629600 · Cited by 206
Spitzer, C., Barnow, S., Völzke, H., Wallaschofski, H., John, U., Freyberger, H. J., Löwe, B., & Grabe, H. J. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.06.002 · Cited by 205
Fleetwood, A. J., Lee, M. K. S., Singleton, W., Achuthan, A., Lee, M.-C., O'Brien-Simpson, N. M., Cook, A. D., Murphy, A. J., Dashper, S. G., Reynolds, E. C., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00351 · Cited by 205
Ehringer, H., & Hornykiewicz, O. (1998) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(98)00012-1 · Cited by 204
Richard, K., Hume, R., Kaptein, E., Stanley, E. L., Visser, T. J., & Coughtrie, M. W. H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7569 · Cited by 204
Lumateperone: a new treatment approach for neuropsychiatric disorders
Kumar, B., Kuhad, A., & Kuhad, A. (2018) · Drugs of Today · doi:10.1358/dot.2018.54.12.2899443 · Cited by 204
Cited by
Uncovering the metabolic impact of acute psychological stress in young adults
Frempong, G. A., Goni, G., Lorenzo-Tejedor, M., De la Cámara, C., Lázaro, J., Mangialavori Rasia, E., Aguiló, J., Bailon, R., & Bernal, M. L. (2026) · Scientific Reports · doi:10.1038/s41598-025-29572-4 · Cited by 3
Metadata
- Authors
- Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 75
- Issue
- 1
- Pages
- 62-158
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W4311937162
- Cited by
- 308
- References
- 1,227
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.